Literature DB >> 11421603

Glutamine enhances the gut-trophic effect of growth hormone in rat after massive small bowel resection.

X Zhou1, Y X Li, N Li, J S Li.   

Abstract

Background. Bowel-specific nutrient, glutamine, growth hormone, and modified diet have been reported to jointly improve nutrient absorption in patients with short bowel syndrome. However, controversy exists about the exact treatment factor. In this study we attempted to analyze the individual and combined effect of glutamine supplementation and growth hormone on small bowel adaptation by using tube feeding to control luminal nutrition supply. Materials and methods. Thirty-two adult male Sprague-Dawley rats (278 +/- 8 g) underwent 85% mid-small bowel resection and were randomly assigned to four groups: Control, receiving control liquid diet via a gastrotomy tube; GLN, receiving liquid diet enriched with 20 g. L(-1) glutamine; GH, receiving subcutaneous growth hormone (GH) (0.3 IU, bid); and GLN + GH, receiving both glutamine supplementation and GH treatment. All animals were provided with isocaloric (60 kcal/day) and isonitrogenous (0.686 g/day) nutrition. Absorption tests were performed in the form of oral nutrient tests with (14)C-labeled glucose and (3)H-labeled palmitic acid on the Postoperative Day 12. Results. GH treatment significantly increased the plasma insulin-like growth factor I (IGF-I) level, body weight, jejunal and ileal villous height and mucosal thickness, and peak plasma (14)C and (3)H levels. Glutamine supplementation did not produce a significant difference; however, combined with GH treatment, glutamine supplementation further increased body weight, plasma IGF-I level, jejunal and ileal villous height and mucosal thickness, and peak plasma (14)C and (3)H levels significantly. Conclusions. After massive small bowel resection, enteral glutamine supplementation alone has no remarkable beneficial effect on bowel adaptation. However, glutamine supplementation enhanced the gut-trophic effect of GH. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421603     DOI: 10.1006/jsre.2001.6108

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

Review 1.  Somatropin (Zorbtive): in short bowel syndrome.

Authors:  Gillian M Keating; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Intestinal mucosal adaptation.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  A randomly coiled, high-molecular-weight polypeptide exhibits increased paracellular diffusion in vitro and in situ relative to the highly ordered alpha-helix conformer.

Authors:  Nazila Salamat-Miller; Montakarn Chittchang; Ashim K Mitra; Thomas P Johnston
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

Review 4.  Growth factors: possible roles for clinical management of the short bowel syndrome.

Authors:  Mark E McMellen; Derek Wakeman; Shannon W Longshore; Lucas A McDuffie; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

Review 5.  Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.

Authors:  Laurie A Drozdowski; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

6.  The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.

Authors:  Yan Gu; Zhao-Han Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 7.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

8.  Effects of recombinant human growth hormone on enterocutaneous fistula patients.

Authors:  Guo-Sheng Gu; Jian-An Ren; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells.

Authors:  Lakshmi S Chaturvedi; Marc D Basson
Journal:  JAMA Surg       Date:  2013-11       Impact factor: 14.766

Review 10.  The Pathogenesis of Resection-Associated Intestinal Adaptation.

Authors:  Brad W Warner
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.